What Researchers Did
Researchers conducted a randomized, double-blind study to see if hyperbaric oxygen therapy could reduce cognitive problems after acute carbon monoxide poisoning.
What They Found
At six weeks, cognitive problems were significantly less common in the hyperbaric oxygen group (19 of 76, or 25.0%) compared to the normobaric oxygen group (35 of 76, or 46.1%). This benefit persisted, with cognitive problems also being less frequent in the hyperbaric oxygen group at 12 months.
What This Means for Canadian Patients
For Canadian patients experiencing acute carbon monoxide poisoning, this study suggests that hyperbaric oxygen therapy can significantly reduce the risk of developing long-term cognitive problems. Early intervention with HBOT may improve patient outcomes and quality of life by mitigating these common and debilitating sequelae.
Canadian Relevance
This study addresses carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
The trial was stopped early after an interim analysis, which is a potential limitation.